Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Solifenacin objectively decreases urinary sensation in women with overactive bladder syndrome.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Solifenacin objectively decreases urinary sensation in women with overactive bladder syndrome.
Solifenacin objectively decreases urinary sensation in women with overactive bladder syndrome. Int Urol Nephrol. 2012 Apr; 44(2):425-9.
View in:
PubMed
subject areas
Aged
Diagnostic Techniques, Urological
Equipment Design
Female
Follow-Up Studies
Humans
Middle Aged
Muscarinic Antagonists
Predictive Value of Tests
Quinuclidines
Reproducibility of Results
Sensation
Solifenacin Succinate
Syndrome
Tetrahydroisoquinolines
Treatment Outcome
Urinary Bladder
Urinary Bladder, Overactive
Urodynamics
authors with profiles
Kimberly Kenton